ABSCO THERAPEUTICS, INC.

ALLSTON, MA · Founded 2024 · Medtech · Still private

Image-guided intratumoral drug delivery system for localized immunotherapy in solid tumors

Claim this profile

Follows are private to you and power your alerts

Updated · abscotx.com

Sector
Medtech
Headquarters
ALLSTON, MA
Founded
2024
Latest Form D
$5M, Aug 2025
Total capital
$7.3M
Federal grants
$305K
1 award · 2025
Rank in peer group#413 of 445
Private capital raised
$7M
2 Form D · last Aug 2025
14 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20242025FEDERAL ↑EQUITY ↓Cumulative $7.3M$305K1st Form D$2M2nd Form D$5M
20242025FEDERAL ↑EQUITY ↓Cumulative $7.3M$305K1st Form D$2M2nd Form D$5M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$5M
  • Federal grantNSF · Phase I · SBIR Phase I: Image-Guided Controlled Release Platform for Intratumoral Immunoadjuvant Delivery$305K
  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Stephen LindermanResearcherExecutive Officer, DirectorLinked by $305K in grants as PI
  • Avik SomDirectorNamed in SEC Form D filings
  • Carlo Giovanni TraversoDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .